Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

0 Visualizações· 09/18/23
OncLive® On Air
OncLive® On Air
0 Assinantes
0
Dentro

Drs Jones and Somaiah discuss unmet needs in GIST that the Peak trial seeks to answer; the advantages of the methods and design of this trial; and how the tolerable safety profile of bezuclastinib plus sunitinib supports further research with this combination.

Mostre mais

 0 Comentários sort   Ordenar por


A seguir